Leading Pharma, LLC recalls ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Phar
Recalled October 5, 2022 · FDA recall D-1546-2022 · Leading Pharma
Hazard
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules · FDA Class III
Units
960 bottles (100 capsules)
Sold at
Nationwide within the United States
Description
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
Product
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
Manufacturer(s)
Leading Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →